Paraphrasing here ... Q&A with Lesley in the video:
Q: So are you thinking about licensing or partnering for these innovations?
A: That's market sensitive, so I can't really talk about it, but yes, that's the trajectory.
Let's hope so. I know a buyout would make our 'when to sell' decision for us, but I fear any buyout figure would leave an awful, awful lot of long-term value on the table.
OOO
Ann: Imugene HER-Vaxx Presentation at AACR 2021 Meeting, page-70
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.001(0.70%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.2¢ | 7.0¢ | $207.3K | 2.925M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 116718 | 7.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 911706 | 19 |
View Market Depth
| Last trade - 10.31am 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
0.001 ( 1.14 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.2¢ | 7.0¢ | 1959525 | ||
| Last updated 10.45am 14/05/2024 ? | |||||
| IMU (ASX) Chart |